Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
GlaxoSmithKline
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Histologically or cytologically confirmed diagnosis of an advanced solid tumor malignancy that is not responsive to standard therapies or for which there is no standard therapy.
ECOG (Eastern Cooperative Oncology Group) Performance Status of 0-2.
Bone marrow function: - ANC greater than 1500/mm3.
Platelet count greater than or equal to 100,000/mm3.
Hemoglobin greater than 9 g/dL.
Renal function: - Calculated creatinine clearance greater than or equal to 50 mL.min.
Total bilirubin greater than 1.5 mg/dL.
AST/ALT less than 2.5 X upper limit of normal.
You may not be if
Females who are pregnant or nursing.
Pre-existing hemolytic anemia.
Pre-existing peripheral neuropathy greater than or equal grade 2.
Known deficiency in dihydropyrimidine dehydrogenase (DSD).
Clareo Health | Ispinesib In Combination With Capecitabine In Patients With Solid Tumors
